Furthermore, NK cells are less motile in tumors lacking NKG2D ligands than those with NKG2D ligands (107), suggesting that targeted blockage of NKG2D ligands in tumors could help retain tumor-infiltrated NK cells within the tumor. The gene discussed is KLRK1; the disease is neoplasm.